SG10201809452RA - Cell culture compositions with antioxidants and methods for polypeptide production - Google Patents
Cell culture compositions with antioxidants and methods for polypeptide productionInfo
- Publication number
- SG10201809452RA SG10201809452RA SG10201809452RA SG10201809452RA SG10201809452RA SG 10201809452R A SG10201809452R A SG 10201809452RA SG 10201809452R A SG10201809452R A SG 10201809452RA SG 10201809452R A SG10201809452R A SG 10201809452RA SG 10201809452R A SG10201809452R A SG 10201809452RA
- Authority
- SG
- Singapore
- Prior art keywords
- methods
- antioxidants
- polypeptide production
- cell culture
- culture compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
- C12N2500/33—Amino acids other than alpha-amino carboxylic acids, e.g. beta-amino acids, taurine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/44—Thiols, e.g. mercaptoethanol
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/46—Amines, e.g. putrescine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361799602P | 2013-03-15 | 2013-03-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10201809452RA true SG10201809452RA (en) | 2018-11-29 |
Family
ID=50639996
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201912621TA SG10201912621TA (en) | 2013-03-15 | 2014-03-14 | Cell culture compositions with antioxidants and methods for polypeptide production |
SG10201809452RA SG10201809452RA (en) | 2013-03-15 | 2014-03-14 | Cell culture compositions with antioxidants and methods for polypeptide production |
SG11201507367PA SG11201507367PA (en) | 2013-03-15 | 2014-03-14 | Cell culture compositions with antioxidants and methods for polypeptide production |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201912621TA SG10201912621TA (en) | 2013-03-15 | 2014-03-14 | Cell culture compositions with antioxidants and methods for polypeptide production |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201507367PA SG11201507367PA (en) | 2013-03-15 | 2014-03-14 | Cell culture compositions with antioxidants and methods for polypeptide production |
Country Status (19)
Country | Link |
---|---|
US (5) | US10017732B2 (pt) |
EP (2) | EP3712252A1 (pt) |
JP (2) | JP6591395B2 (pt) |
KR (2) | KR102235452B1 (pt) |
CN (2) | CN110951670A (pt) |
AU (3) | AU2014233393B2 (pt) |
BR (1) | BR112015021993A8 (pt) |
CA (1) | CA2903596C (pt) |
ES (1) | ES2798307T3 (pt) |
HK (1) | HK1218141A1 (pt) |
HR (1) | HRP20200893T1 (pt) |
IL (2) | IL240644B (pt) |
MX (2) | MX360779B (pt) |
PL (1) | PL2970875T3 (pt) |
RU (2) | RU2020111947A (pt) |
SG (3) | SG10201912621TA (pt) |
SI (1) | SI2970875T1 (pt) |
WO (1) | WO2014145098A1 (pt) |
ZA (2) | ZA201506155B (pt) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX360779B (es) | 2013-03-15 | 2018-11-16 | Genentech Inc | Composiciones de cultivo celular con antioxidantes y métodos para la producción de polipéptidos. |
WO2014182658A1 (en) * | 2013-05-06 | 2014-11-13 | Abbvie Inc. | Compositions for cell culture and methods of using the same |
MA40864A (fr) * | 2014-10-31 | 2017-09-05 | Biogen Ma Inc | Hypotaurine, gaba, bêta-alanine et choline pour la régulation de l'accumulation de sous-produits résiduaires dans des procédés de culture de cellules mammifères |
TW202330904A (zh) | 2015-08-04 | 2023-08-01 | 美商再生元醫藥公司 | 補充牛磺酸之細胞培養基及用法 |
US11254964B1 (en) * | 2016-03-15 | 2022-02-22 | Fresenius Kabi Deutschland Gmbh | Cell culture methods for increased cell viability |
US11186858B1 (en) | 2016-03-15 | 2021-11-30 | Fresenius Kabi Deutschland Gmbh | Methods for increasing biosimilarity |
SG11201809959PA (en) * | 2016-05-10 | 2018-12-28 | Genentech Inc | Methods of decreasing trisulfide bonds during recombinant production of polypeptides |
CN106070537A (zh) * | 2016-07-08 | 2016-11-09 | 广东海洋大学 | 一种抑制虾黑变的抗氧化剂及其制备方法与应用 |
EP3807399A1 (en) * | 2018-07-13 | 2021-04-21 | Lonza Ltd. | Methods for improving production of biological products by reducing the level of endogenous protein |
EP3875595A4 (en) * | 2018-11-02 | 2022-07-13 | Kyowa Kirin Co., Ltd. | METHOD FOR PREPARING LIQUID CULTURE MEDIUM |
HUP1800376A2 (hu) * | 2018-11-07 | 2020-05-28 | Richter Gedeon Nyrt | Sejttenyészetben elõállított rekombináns glikoprotein glikozilációs-mintázatának megváltoztatására szolgáló módszer |
BR112021025769A2 (pt) | 2019-12-06 | 2022-04-12 | Regeneron Pharma | Composições de proteína anti-vegf e métodos para a produção das mesmas |
WO2023194946A1 (en) * | 2022-04-06 | 2023-10-12 | Kashiv Biosciences, Llc | An improved cell culture process for production of protein |
Family Cites Families (105)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE266710C (pt) | ||||
US3883511A (en) | 1974-03-07 | 1975-05-13 | Rit Rech Ind Therapeut | New 6-aminopenicillanic acid derivative |
USRE30985E (en) | 1978-01-01 | 1982-06-29 | Serum-free cell culture media | |
FR2413974A1 (fr) | 1978-01-06 | 1979-08-03 | David Bernard | Sechoir pour feuilles imprimees par serigraphie |
US4419446A (en) | 1980-12-31 | 1983-12-06 | The United States Of America As Represented By The Department Of Health And Human Services | Recombinant DNA process utilizing a papilloma virus DNA as a vector |
NZ201705A (en) | 1981-08-31 | 1986-03-14 | Genentech Inc | Recombinant dna method for production of hepatitis b surface antigen in yeast |
US4601978A (en) | 1982-11-24 | 1986-07-22 | The Regents Of The University Of California | Mammalian metallothionein promoter system |
US4560655A (en) | 1982-12-16 | 1985-12-24 | Immunex Corporation | Serum-free cell culture medium and process for making same |
US4657866A (en) | 1982-12-21 | 1987-04-14 | Sudhir Kumar | Serum-free, synthetic, completely chemically defined tissue culture media |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
DD266710A3 (de) | 1983-06-06 | 1989-04-12 | Ve Forschungszentrum Biotechnologie | Verfahren zur biotechnischen Herstellung van alkalischer Phosphatase |
US4767704A (en) | 1983-10-07 | 1988-08-30 | Columbia University In The City Of New York | Protein-free culture medium |
US4965199A (en) | 1984-04-20 | 1990-10-23 | Genentech, Inc. | Preparation of functional human factor VIII in mammalian cells using methotrexate based selection |
US4879231A (en) | 1984-10-30 | 1989-11-07 | Phillips Petroleum Company | Transformation of yeasts of the genus pichia |
GB8516415D0 (en) | 1985-06-28 | 1985-07-31 | Celltech Ltd | Culture of animal cells |
US4676980A (en) | 1985-09-23 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target specific cross-linked heteroantibodies |
US4927762A (en) | 1986-04-01 | 1990-05-22 | Cell Enterprises, Inc. | Cell culture medium with antioxidant |
GB8610600D0 (en) | 1986-04-30 | 1986-06-04 | Novo Industri As | Transformation of trichoderma |
IL87737A (en) | 1987-09-11 | 1993-08-18 | Genentech Inc | Method for culturing polypeptide factor dependent vertebrate recombinant cells |
CA1338518C (en) | 1987-09-23 | 1996-08-13 | Joyce M. Zarling | Antibody heteroconjugates for the killing of hiv-infected cells |
AU632065B2 (en) | 1988-09-23 | 1992-12-17 | Novartis Vaccines And Diagnostics, Inc. | Cell culture medium for enhanced cell growth, culture longevity and product expression |
GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
ATE102631T1 (de) | 1988-11-11 | 1994-03-15 | Medical Res Council | Klonierung von immunglobulin sequenzen aus den variabelen domaenen. |
FR2646437B1 (fr) | 1989-04-28 | 1991-08-30 | Transgene Sa | Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant |
EP0402226A1 (en) | 1989-06-06 | 1990-12-12 | Institut National De La Recherche Agronomique | Transformation vectors for yeast yarrowia |
AU641673B2 (en) | 1989-06-29 | 1993-09-30 | Medarex, Inc. | Bispecific reagents for aids therapy |
US5959177A (en) | 1989-10-27 | 1999-09-28 | The Scripps Research Institute | Transgenic plants expressing assembled secretory antibodies |
EP0463151B1 (en) | 1990-01-12 | 1996-06-12 | Cell Genesys, Inc. | Generation of xenogeneic antibodies |
JP3230091B2 (ja) | 1990-06-25 | 2001-11-19 | ウェルファイド株式会社 | ヒト血清アルブミンの着色抑制方法 |
US5633425A (en) | 1990-08-29 | 1997-05-27 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
US5625126A (en) | 1990-08-29 | 1997-04-29 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
ES2108048T3 (es) | 1990-08-29 | 1997-12-16 | Genpharm Int | Produccion y utilizacion de animales inferiores transgenicos capaces de producir anticuerpos heterologos. |
US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
US5661016A (en) | 1990-08-29 | 1997-08-26 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
US5122469A (en) | 1990-10-03 | 1992-06-16 | Genentech, Inc. | Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins |
DE69132032T2 (de) * | 1990-11-23 | 2000-12-21 | Peptech Ltd | Verzögerung, verhinderung und/oder rückgängigmachen von zellalterung |
DE69129154T2 (de) | 1990-12-03 | 1998-08-20 | Genentech Inc | Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften |
US5571894A (en) | 1991-02-05 | 1996-11-05 | Ciba-Geigy Corporation | Recombinant antibodies specific for a growth factor receptor |
WO1992020373A1 (en) | 1991-05-14 | 1992-11-26 | Repligen Corporation | Heteroconjugate antibodies for treatment of hiv infection |
EP0861893A3 (en) | 1991-09-19 | 1999-11-10 | Genentech, Inc. | High level expression of immunoglobulin polypeptides |
EP0605522B1 (en) | 1991-09-23 | 1999-06-23 | Medical Research Council | Methods for the production of humanized antibodies |
US5587458A (en) | 1991-10-07 | 1996-12-24 | Aronex Pharmaceuticals, Inc. | Anti-erbB-2 antibodies, combinations thereof, and therapeutic and diagnostic uses thereof |
WO1993008829A1 (en) | 1991-11-04 | 1993-05-13 | The Regents Of The University Of California | Compositions that mediate killing of hiv-infected cells |
US5667988A (en) | 1992-01-27 | 1997-09-16 | The Scripps Research Institute | Methods for producing antibody libraries using universal or randomized immunoglobulin light chains |
WO1993016185A2 (en) | 1992-02-06 | 1993-08-19 | Creative Biomolecules, Inc. | Biosynthetic binding protein for cancer marker |
CA2131444A1 (en) | 1992-03-04 | 1993-09-16 | Kelli E. Smith | Dna encoding taurine and gaba transporters and uses thereof |
JPH07102147B2 (ja) * | 1992-03-16 | 1995-11-08 | 株式会社ミドリ十字 | ヒト血清アルブミンの着色抑制方法 |
AU668423B2 (en) | 1992-08-17 | 1996-05-02 | Genentech Inc. | Bispecific immunoadhesins |
ATE196606T1 (de) | 1992-11-13 | 2000-10-15 | Idec Pharma Corp | Therapeutische verwendung von chimerischen und markierten antikörpern, die gegen ein differenzierung-antigen gerichtet sind, dessen expression auf menschliche b lymphozyt beschränkt ist, für die behandlung von b-zell-lymphoma |
US5856179A (en) | 1994-03-10 | 1999-01-05 | Genentech, Inc. | Polypeptide production in animal cell culture |
US5789199A (en) | 1994-11-03 | 1998-08-04 | Genentech, Inc. | Process for bacterial production of polypeptides |
US5840523A (en) | 1995-03-01 | 1998-11-24 | Genetech, Inc. | Methods and compositions for secretion of heterologous polypeptides |
US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
US5641870A (en) | 1995-04-20 | 1997-06-24 | Genentech, Inc. | Low pH hydrophobic interaction chromatography for antibody purification |
US5869046A (en) | 1995-04-14 | 1999-02-09 | Genentech, Inc. | Altered polypeptides with increased half-life |
CA2219361C (en) | 1995-04-27 | 2012-02-28 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
WO1996034096A1 (en) | 1995-04-28 | 1996-10-31 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
US6267958B1 (en) | 1995-07-27 | 2001-07-31 | Genentech, Inc. | Protein formulation |
EP1500329B1 (en) | 1996-12-03 | 2012-03-21 | Amgen Fremont Inc. | Human antibodies that specifically bind human TNF alpha |
US20080318254A9 (en) | 1997-03-10 | 2008-12-25 | The Regents Of The University Of California | PSCA antibodies and hybridomas producing them |
US20020012991A1 (en) * | 1997-04-07 | 2002-01-31 | Florence Chua Nee Ho Kit Fong | Cell culture media for enhanced protein production |
US20020173629A1 (en) | 1997-05-05 | 2002-11-21 | Aya Jakobovits | Human monoclonal antibodies to epidermal growth factor receptor |
US6171586B1 (en) | 1997-06-13 | 2001-01-09 | Genentech, Inc. | Antibody formulation |
AU7984498A (en) * | 1997-06-25 | 1999-01-04 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Serum-free cell growth medium |
US6040498A (en) | 1998-08-11 | 2000-03-21 | North Caroline State University | Genetically engineered duckweed |
US6610833B1 (en) | 1997-11-24 | 2003-08-26 | The Institute For Human Genetics And Biochemistry | Monoclonal human natural antibodies |
EP1167537B1 (en) | 1999-03-30 | 2008-07-23 | Japan Tobacco Inc. | Process for producing monoclonal antibody |
US7125978B1 (en) | 1999-10-04 | 2006-10-24 | Medicago Inc. | Promoter for regulating expression of foreign genes |
PT1222292E (pt) | 1999-10-04 | 2005-11-30 | Medicago Inc | Metodo para regulacao da transcricao de genes exogenos na presenca de azoto |
RU2192884C2 (ru) * | 2000-11-09 | 2002-11-20 | Государственное учреждение Научно-исследовательский институт клинической иммунологии СО РАМН | Вакцина для стимуляции противоопухолевого иммунитета |
US7311905B2 (en) * | 2002-02-13 | 2007-12-25 | Anthrogenesis Corporation | Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells |
JP2005519580A (ja) | 2001-05-16 | 2005-07-07 | アルバート アインシュタイン カレッジ オブ メディシン オブ イエシバ ユニバーシティ | 非ヒト動物由来のヒト抗肺炎球菌抗体 |
AU2002316230A1 (en) | 2001-06-13 | 2002-12-23 | Genentech, Inc. | Methods of culturing animal cells and polypeptide production in animal cells |
MXPA04001486A (es) | 2001-08-23 | 2004-10-27 | Genmab As | Anticuerpos humanos especificos para interleucina 15 (il-15). |
US7371922B2 (en) * | 2002-07-31 | 2008-05-13 | The Board Of Trustees Of The University Of Illinois | Nuclear transfer with porcine embryonic stem cells |
ES2373947T3 (es) | 2002-12-16 | 2012-02-10 | Genmab A/S | Anticuerpos monoclonales humanos contra interleucina 8 (il-8). |
EP3263596A1 (en) * | 2002-12-16 | 2018-01-03 | Genentech, Inc. | Immunoglobulin variants and uses thereof |
JP2007525410A (ja) | 2003-01-17 | 2007-09-06 | ザ リサーチ ファンデーション オブ ステイト ユニバーシティ オブ ニューヨーク | 膵臓癌に関連する抗原、それらに対する抗体、及び診断方法及び処置方法 |
US7807458B2 (en) * | 2003-01-30 | 2010-10-05 | The United States Of America As Represented By The Secretary Of The Department Of Veterans Affairs | Multilineage-inducible cells and uses thereof |
EP1633785B1 (en) | 2003-05-21 | 2012-11-28 | Medarex, Inc. | Human monoclonal antibodies against bacillusanthracis protective antigen |
JO3000B1 (ar) | 2004-10-20 | 2016-09-05 | Genentech Inc | مركبات أجسام مضادة . |
US20060115901A1 (en) | 2004-10-22 | 2006-06-01 | Bahram Valamehr | Method and media for single cell serum-free culture of CHO cells |
US7598083B2 (en) | 2004-10-29 | 2009-10-06 | Centocor, Inc. | Chemically defined media compositions |
ES2498794T3 (es) * | 2005-02-18 | 2014-09-25 | Medarex, L.L.C. | Anticuerpos monoclonales contra CD30 que carecen de restos fucosilo |
AU2006240079A1 (en) | 2005-04-21 | 2006-11-02 | Glenn A. Goldstein | N-acetylcysteine amide (NAC amide) for treatment of oxidative stress associated with infertility |
BRPI0612972A2 (pt) * | 2005-04-22 | 2010-12-14 | Genentech Inc | mÉtodo para tratar doenÇa de alzheimer, mÉtodo para tratar demÊncia, artigo de fabricaÇço e usos de um anticorpo cd20 |
AU2006247039B2 (en) * | 2005-05-19 | 2011-03-03 | Amgen Inc. | Compositions and methods for increasing the stability of antibodies |
PE20070796A1 (es) * | 2005-10-24 | 2007-08-15 | Wyeth Corp | Metodo de produccion proteica utilizando compuestos anti-senescencia |
WO2007146123A2 (en) | 2006-06-09 | 2007-12-21 | Anthrogenesis Corporation | Placental niche and use thereof to culture stem cells |
TW200902708A (en) * | 2007-04-23 | 2009-01-16 | Wyeth Corp | Methods of protein production using anti-senescence compounds |
BRPI0815036B1 (pt) | 2007-08-07 | 2022-09-20 | Chugai Seiyaku Kabushiki Kaisha | Métodos para produção de um polipeptídeo e para preparação de um produto farmacêutico |
JP5642549B2 (ja) | 2007-10-12 | 2014-12-17 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | 複数の核酸からのタンパク質発現 |
CN101418330B (zh) * | 2008-06-20 | 2012-01-04 | 华东理工大学 | 适于nso细胞大规模培养及抗体生产的无蛋白培养基 |
NZ591651A (en) * | 2008-09-26 | 2012-12-21 | Merck Sharp & Dohme | High titer antibody production and culture media comprising glucose, soy or wheat hydrolsyate, amino acids, and other chemical compounds |
CN101603026B (zh) * | 2009-06-19 | 2011-01-19 | 华东理工大学 | 适于动物细胞产品生产的无动物来源低蛋白培养基 |
EP2453874A2 (en) | 2009-07-14 | 2012-05-23 | Biogen Idec MA Inc. | Methods for inhibiting yellow color and peroxide formation in a composition |
US8512983B2 (en) | 2009-08-11 | 2013-08-20 | Martin Gawlitzek | Production of proteins in glutamine-free cell culture media |
KR101828624B1 (ko) | 2010-04-26 | 2018-02-12 | 노파르티스 아게 | 개선된 세포 배양 방법 |
CN103270416A (zh) * | 2010-11-05 | 2013-08-28 | Abbvie公司 | 用于开发细胞培养中化学限定培养基的高效和有效补充物筛选 |
CN102093978A (zh) * | 2010-12-17 | 2011-06-15 | 上海市农业科学院 | 猪早期胚胎发育前期培养液及后期培养液 |
WO2012092458A2 (en) * | 2010-12-30 | 2012-07-05 | Anthrogenesis Corporation | Compositions comprising placental stem cells and platelet rich plasma, and methods of use thereof |
US20150267237A1 (en) * | 2012-04-24 | 2015-09-24 | Genentech, Inc. | Cell culture compositions and methods for polypeptide production |
US20130281355A1 (en) * | 2012-04-24 | 2013-10-24 | Genentech, Inc. | Cell culture compositions and methods for polypeptide production |
CN204634080U (zh) | 2012-08-20 | 2015-09-09 | 施雷德公司 | 将led光源与电浪涌隔离的***以及包括该***的光源 |
MX360779B (es) | 2013-03-15 | 2018-11-16 | Genentech Inc | Composiciones de cultivo celular con antioxidantes y métodos para la producción de polipéptidos. |
-
2014
- 2014-03-14 MX MX2015012875A patent/MX360779B/es active IP Right Grant
- 2014-03-14 EP EP20168621.9A patent/EP3712252A1/en active Pending
- 2014-03-14 CN CN201911337799.2A patent/CN110951670A/zh active Pending
- 2014-03-14 PL PL14721668T patent/PL2970875T3/pl unknown
- 2014-03-14 ES ES14721668T patent/ES2798307T3/es active Active
- 2014-03-14 RU RU2020111947A patent/RU2020111947A/ru unknown
- 2014-03-14 US US14/211,416 patent/US10017732B2/en active Active
- 2014-03-14 JP JP2016503220A patent/JP6591395B2/ja active Active
- 2014-03-14 AU AU2014233393A patent/AU2014233393B2/en active Active
- 2014-03-14 SG SG10201912621TA patent/SG10201912621TA/en unknown
- 2014-03-14 WO PCT/US2014/029772 patent/WO2014145098A1/en active Application Filing
- 2014-03-14 SG SG10201809452RA patent/SG10201809452RA/en unknown
- 2014-03-14 CN CN201480014227.XA patent/CN105121628B/zh active Active
- 2014-03-14 BR BR112015021993A patent/BR112015021993A8/pt not_active Application Discontinuation
- 2014-03-14 EP EP14721668.3A patent/EP2970875B1/en active Active
- 2014-03-14 KR KR1020157028514A patent/KR102235452B1/ko active IP Right Grant
- 2014-03-14 RU RU2015144172A patent/RU2718986C2/ru active
- 2014-03-14 CA CA2903596A patent/CA2903596C/en active Active
- 2014-03-14 SG SG11201507367PA patent/SG11201507367PA/en unknown
- 2014-03-14 SI SI201431588T patent/SI2970875T1/sl unknown
- 2014-03-14 KR KR1020217009254A patent/KR20210037745A/ko not_active Application Discontinuation
-
2015
- 2015-08-18 IL IL240644A patent/IL240644B/en active IP Right Grant
- 2015-08-24 ZA ZA2015/06155A patent/ZA201506155B/en unknown
- 2015-09-11 US US14/852,311 patent/US10131873B2/en active Active
- 2015-09-14 MX MX2018014043A patent/MX2018014043A/es unknown
-
2016
- 2016-05-31 HK HK16106171.0A patent/HK1218141A1/zh unknown
-
2018
- 2018-06-04 US US15/997,342 patent/US10676710B2/en active Active
- 2018-08-23 ZA ZA201805630A patent/ZA201805630B/en unknown
- 2018-10-04 US US16/151,904 patent/US10829732B2/en active Active
-
2019
- 2019-03-27 JP JP2019060156A patent/JP6843911B2/ja active Active
-
2020
- 2020-03-22 IL IL273504A patent/IL273504A/en unknown
- 2020-06-04 HR HRP20200893TT patent/HRP20200893T1/hr unknown
- 2020-08-24 AU AU2020223634A patent/AU2020223634A1/en not_active Abandoned
- 2020-10-05 US US17/063,322 patent/US20210017488A1/en not_active Abandoned
-
2022
- 2022-09-14 AU AU2022231703A patent/AU2022231703A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG10201809452RA (en) | Cell culture compositions with antioxidants and methods for polypeptide production | |
MX2019003427A (es) | Composiciones para cultivo celular y metodos para la produccion de polipeptidos. | |
MX2021008143A (es) | Metodos para cosechar cultivos de celulas de mamifero. | |
MX2018005274A (es) | Metodos para la generacion de celulas-t a partir de celulas madre y metodos inmunoterapeuticos que utilizan las celulas-t. | |
WO2012019122A3 (en) | Simplified basic media for human pluripotent cell culture | |
EP3546570A4 (en) | KIT WITH MEDIUM FOR THE CULTURE OF SERUM-FREE IMMUNELL CELLS, METHOD FOR THE CULTURE OF IMMUNAL CELLS BY USE OF THE KIT, SERUM-FREE IMMUNE CELL CULTURE RECEIVED BY THE KIT OR CULTURE METHOD AND COSMETIC COMPOSITION | |
MX2015011781A (es) | Medio de cultivo celular y metodos de produccion de anticuerpos. | |
MX2016014235A (es) | Biosintesis microbiana de ergotioneina. | |
EP4292600A3 (en) | Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells | |
GB2548740A (en) | Methods for generation of podocytes from pluripotent stem cells and cells produced by the same | |
EP3263697A4 (en) | Culture medium for culturing mesenchymal stem cell, method for culturing mesenchymal stem cell, and mesenchymal stem cell | |
MX2020009670A (es) | Metodos de cultivo por perfusion y usos de los mismos. | |
EA201492185A1 (ru) | Способ получения рекомбинантной идуронат-2-сульфатазы | |
MX2020001357A (es) | Produccion microbiana de aminas grasas. | |
MX2021001981A (es) | Metodos para preparar un poloxamero para usar en medio de cultivo celular. | |
EP3511410A4 (en) | MEDIUM FOR THE CULTURE OF STEM CELLS, METHOD FOR THE CULTURE OF STEM CELLS, STEM CELL GROWTH PROMOTER AND COMPOSITION AND METHOD FOR THE PRODUCTION THEREOF | |
WO2014049382A3 (en) | Ethylenediamine fermentative production by a recombinant microorganism | |
MX2022000516A (es) | Metodos relacionados con celulas pluripotentes. | |
EP3684798A4 (en) | CELL CULTURE ADDITIVES AND THEIR USE IN THE INCREASED PRODUCTION OF BIOPROTEINS FROM CELLS | |
SG10201808061WA (en) | Method for the clarification of high density crude cell culture harvest | |
WO2015117033A3 (en) | Methods of increasing protein production in mammalian cells | |
EP3150700A4 (en) | Culture medium and culturing method for anchorage-dependent cells, cell composition including stem cells and/or differentiated cells derived from stem cells, and production method for cell composition | |
MX2021012649A (es) | Medio de cultivo celular para celulas eucarioticas. | |
MX2014012407A (es) | Metodo para incrementar la secrecion de proteinas recombinantes. | |
MX2018013683A (es) | Métodos para disminuir los enlaces de trisulfuro durante la producción recombinante de polipéptidos. |